Netols Asset Management’s Integra LifeSciences IART Stock Holding History

Netols Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$7.01M	Sell	166,444 -14,648	-8%	-$626K	1.58%	24
2016 Q4	$7.77M	Sell	181,092 -7,980	-4%	-$324K	1.6%	26
2016 Q3	$7.8M	Sell	189,072 -3,964	-2%	-$166K	1.73%	18
2016 Q2	$7.7M	Sell	193,036 -47,762	-20%	-$1.72M	1.74%	19
2016 Q1	$8.11M	Sell	240,798 -32,446	-12%	-$1.01M	1.8%	18
2015 Q4	$9.26M	Buy	273,244 +1,366	+0.5%	+$42.7K	2.05%	7
2015 Q3	$8.1M	Sell	271,878 -67,546	-20%	-$2.11M	1.83%	13
2015 Q2	$9.35M	Sell	339,424 -6,921	-2%	-$184K	1.84%	12
2015 Q1	$8.73M	Sell	346,345 -9,852	-3%	-$233K	1.7%	13
2014 Q4	$7.9M	Sell	356,197 -38,531	-10%	-$781K	1.52%	26
2014 Q3	$8.01M	Sell	394,728 -41,052	-9%	-$817K	1.52%	24
2014 Q2	$8.38M	Buy	435,780 +13,365	+3%	+$249K	1.35%	38
2014 Q1	$7.94M	Sell	422,415 -31,751	-7%	-$613K	1.27%	47
2013 Q4	$8.86M	Buy	+454,166	New	+$8.33M	1.34%	36

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Netols Asset Management's IART Position: Q1 2017 in Review

Netols Asset Management reduced its Integra LifeSciences (IART) stake by 8.1% in Q1 2017, selling an estimated $626K and leaving 166,444 shares worth $7.01M. The position accounts for 1.58% of the portfolio, ranked #24.

Netols Asset Management first reported a position in IART in Q4 2013 and has held it in 14 quarters since. The position peaked at $9.35M in Q2 2015. 236 funds tracked by Wall St. Rank hold IART as of Q1 2017.

Netols Asset Management held 166,444 shares of Integra LifeSciences worth $7.01M as of Q1 2017.
Netols Asset Management sold 14,648 Integra LifeSciences shares in Q1 2017, an estimated $626K.
Integra LifeSciences made up 1.58% of Netols Asset Management's portfolio in Q1 2017, its #24 holding.
Netols Asset Management first reported a position in Integra LifeSciences in Q4 2013 and has held it in 14 quarters since.
Netols Asset Management's Integra LifeSciences position peaked at $9.35M in Q2 2015.
236 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2017.

Based on Netols Asset Management's 13F filing for Q1 2017, filed 10 May 2017.